INSP vs. GMED, PEN, GKOS, HAE, MMSI, TFX, AXNX, IRTC, PRCT, and IART
Should you be buying Inspire Medical Systems stock or one of its competitors? The main competitors of Inspire Medical Systems include Globus Medical (GMED), Penumbra (PEN), Glaukos (GKOS), Haemonetics (HAE), Merit Medical Systems (MMSI), Teleflex (TFX), Axonics (AXNX), iRhythm Technologies (IRTC), PROCEPT BioRobotics (PRCT), and Integra LifeSciences (IART). These companies are all part of the "surgical & medical instruments" industry.
Globus Medical (NYSE:GMED) and Inspire Medical Systems (NYSE:INSP) are both mid-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, profitability, analyst recommendations, dividends, earnings, risk, community ranking, media sentiment and valuation.
Globus Medical currently has a consensus target price of $66.33, indicating a potential upside of 28.95%. Inspire Medical Systems has a consensus target price of $272.20, indicating a potential upside of 16.13%. Given Inspire Medical Systems' higher possible upside, research analysts clearly believe Globus Medical is more favorable than Inspire Medical Systems.
Globus Medical has a beta of 1.08, suggesting that its stock price is 8% more volatile than the S&P 500. Comparatively, Inspire Medical Systems has a beta of 1.37, suggesting that its stock price is 37% more volatile than the S&P 500.
Globus Medical has higher revenue and earnings than Inspire Medical Systems. Inspire Medical Systems is trading at a lower price-to-earnings ratio than Globus Medical, indicating that it is currently the more affordable of the two stocks.
In the previous week, Inspire Medical Systems had 13 more articles in the media than Globus Medical. MarketBeat recorded 15 mentions for Inspire Medical Systems and 2 mentions for Globus Medical. Globus Medical's average media sentiment score of 1.04 beat Inspire Medical Systems' score of 0.91 indicating that Inspire Medical Systems is being referred to more favorably in the news media.
Globus Medical received 366 more outperform votes than Inspire Medical Systems when rated by MarketBeat users. Likewise, 67.83% of users gave Globus Medical an outperform vote while only 61.11% of users gave Inspire Medical Systems an outperform vote.
Globus Medical has a net margin of 7.83% compared to Globus Medical's net margin of -3.39%. Inspire Medical Systems' return on equity of 8.82% beat Globus Medical's return on equity.
95.2% of Globus Medical shares are owned by institutional investors. Comparatively, 94.9% of Inspire Medical Systems shares are owned by institutional investors. 24.3% of Globus Medical shares are owned by company insiders. Comparatively, 4.1% of Inspire Medical Systems shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
Summary
Globus Medical beats Inspire Medical Systems on 12 of the 18 factors compared between the two stocks.
Get Inspire Medical Systems News Delivered to You Automatically
Sign up to receive the latest news and ratings for INSP and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding INSP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Inspire Medical Systems Competitors List
Related Companies and Tools
